0001209191-20-036700.txt : 20200615 0001209191-20-036700.hdr.sgml : 20200615 20200615173440 ACCESSION NUMBER: 0001209191-20-036700 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200615 FILED AS OF DATE: 20200615 DATE AS OF CHANGE: 20200615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DARCY THOMAS E CENTRAL INDEX KEY: 0001126910 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38052 FILM NUMBER: 20964352 MAIL ADDRESS: STREET 1: C/O SCIENCE APPLICATIONS INTL CORP STREET 2: 10260 CAMPUS POINT DR. CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tocagen Inc CENTRAL INDEX KEY: 0001419041 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 412-8400 MAIL ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-15 0 0001419041 Tocagen Inc TOCA 0001126910 DARCY THOMAS E C/O TOCAGEN INC. 4445 EASTGATE MALL, SUITE 200 SAN DIEGO CA 92121 1 0 0 0 Common Stock 2020-06-15 4 A 0 1858 0.00 A 1858 D Common Stock 24637 I By Thomas Eric Darcy and Janet E. Darcy, Trustees of the Darcy Family Trust dated September 21, 2001 On January 9, 2020, the Reporting Person was granted a restricted stock unit award under the Issuer's 2017 Equity Incentive Plan subject to satisfaction of certain performance conditions that were established at the time of the Board's approval of the award on January 9, 2020. The performance conditions were satisfied on June 15, 2020. Reflects a 15-to-1 reverse stock split which became effective on June 15, 2020. Thomas E. Darcy 2020-06-15